KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas

In this study, we examined the clinical significance of KRAS and MAPK1 amplification and assessed whether these amplified genes were potential therapeutic targets in type II ovarian carcinoma. Using fluorescence in situ hybridization, immunohistochemistry, and retrospectively collected clinical data...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Mohammed Tanjimur, Nakayama, Kentaro, Rahman, Munmun, Katagiri, Hiroshi, Katagiri, Atsuko, Ishibashi, Tomoka, Ishikawa, Masako, Sato, Emi, Iida, Kouji, Nakayama, Naomi, Ishikawa, Noriyuki, Miyazaki, Kohji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742215/
https://www.ncbi.nlm.nih.gov/pubmed/23820584
http://dx.doi.org/10.3390/ijms140713748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742215/
https://www.ncbi.nlm.nih.gov/pubmed/23820584
http://dx.doi.org/10.3390/ijms140713748

Ejemplares similares